Could a diabetes pill protect hearts in tough-to-treat hypertension?
NCT ID NCT06804161
First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests whether a type of diabetes medicine (SGLT2 inhibitor) can reduce heart attacks, strokes, and other heart problems in people aged 60+ with high blood pressure and a history of heart or blood vessel disease. About 3,000 participants will take either the drug or a placebo alongside their usual treatments. The goal is to see if adding this drug helps control blood pressure and prevents further damage to the heart and blood vessels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universität zu Lübeck
RECRUITINGLübeck, Schleswig-Holstein, 23538, Germany
Contact
Contact
Conditions
Explore the condition pages connected to this study.